Australia Stock Exchange release from AUSCANN GROUP HO : AusCann to Accelerate Human Drug Development Program
Australia Stock Exchange release from AUSCANN GROUP HO AC8.AX : AusCann to Accelerate Human Drug Development Program
Recent news on Auscann group
See all newsBrief: Auscann Group Says Non-Binding Term Sheet Signed To Acquire 100% Shares In Ecc Pharm
Brief: Auscann Says Has Reduced Operating Costs Over Partial Divestment Of Animal Health Assets
Brief: Auscann Group Intends To Offer A Share Purchase Plan
Brief: Auscann Group Appoints Andrew Chapman As Non-Executive Chairman
Brief: Auscann Enters New Loan Agreements With European Cannabis Corporation